Posted on 8/2/17
Merck's Keytruda Plays Catch-Up to Bristol-Myers' Opdivo
Merck & Co (NYSE:MRK) and Bristol-Myers Squibb (NYSE:BMY) are engaged in a battle of sorts. The two won FDA approval for new non-small cell lung cancer . . .
Posted on 8/2/17
Spectrum Pharmacy Products Announces New Partnership with Independent Pharmacy Alliance
Spectrum Pharmacy Products, a leading global manufacturer and distributor of pharmaceutical compounding chemicals, equipment and supplies, announced its partnership with Independent Pharmacy Alliance (IPA), a trade . . .
Posted on 8/2/17
Strenuus, Now Zelis Network Analytics, Selected as a 2017 Inc. Best Workplaces Honoree
BEDMINSTER, N.J. & ATLANTA--(BUSINESS WIRE)--Zelis Healthcare, a market-leading healthcare information technology company, is pleased to announce that Strenuus, now Zelis Network Analytics, has earned a spot . . .
Posted on 8/1/17
Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2017 Financial Results
RADNOR, Pa., Aug. 01, 2017 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc.(Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric . . .
Posted on 7/31/17
Cantel Medical to Acquire BHT Group in Germany
CANTEL MEDICAL CORP. (NYSE:CMD), a leading global company dedicated to delivering innovative infection prevention products, services and solutions
Posted on 7/31/17
Celgene Corporation Continues to Get It Done
Celgene (NASDAQ:CELG) continues to grow revenue with its top-three drugs all experiencing sales growth of at least 20% year over year in the second quarter. The . . .
Posted on 7/31/17
3 Things You Can Expect With Pfizer's Q2 Results
There was good news and bad news for Pfizer (NYSE:PFE) the last time it reported quarterly results. In May, the big drugmaker announced earnings for the . . .
Posted on 7/28/17
Elite Announces Co-Development of Four Additional Products with SunGen Pharma
NORTHVALE, N.J., July 28, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products, today announced Elite . . .
Posted on 7/28/17
Pernix Therapeutics Provides Business Update
MORRISTOWN, N.J., July 27, 2017 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, today announced financial results for the three and six . . .
Posted on 7/28/17
Ortho Clinical Diagnostics Awarded Distinguished #1 Ranking for Service Performance for 2nd Year in a Row
Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, today announced that, for the second year in a row, the Ortho Care service and . . .
Posted on 7/28/17
Vidant Health & PMD Healthcare Collaborate
Chronic Obstruction Pulmonary Disease (COPD) is the 3rd leading cause of mortality in the United States. Additionally, readmission rates for this patient population are among the . . .
Posted on 7/28/17
VenatoRx Pharmaceuticals Receives $9.4 Million Award from CARB-X
MALVERN, Pa.--(BUSINESS WIRE)--VenatoRx Pharmaceuticals, a private company dedicated to the discovery and development of novel therapies for highly drug resistant bacterial infections, announced that it has . . .
Posted on 7/28/17
REPEAT/AstraZeneca and Merck Establish Strategic Oncology Collaboration
KENILWORTH, N.J.--(BUSINESS WIRE)--AstraZeneca and Merck & Co., Inc., (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that they have entered . . .
Posted on 7/27/17
Now Is A Good Time To Buy Johnson & Johnson
Why is it so depressed now?Perhaps because “the street” got over-enthusiastic, EPS are likely to be a bit less than projected, and some analysts have “downgraded” . . .
Posted on 7/27/17
Pfizer Doesn't Want To Be Left In the Dust Of Avastin Biosimilar
Recently, Pfizer (PFE) announced it had achieved positive phase 3 results for its biosimilar candidate of Roche's (OTCQX:RHHBY) Avastin. Pfizer's biosimilar in question is known as . . .
Posted on 7/27/17
Pfizer's Worrying Trend
In my last article about Pfizer (PFE) I discussed the upcoming loss of exclusivity (LOE) of certain brands and why I did not believe these would . . .
Posted on 7/27/17
Eastern Dental Opens New Dental Office In Hackensack
Eastern Dental today announces the opening of a new dental office at 450 Hackensack Ave. in Hackensack, Eastern Dental's 22nd location in the New Jersey area. . . .
Posted on 7/27/17
Eagle Pharmaceuticals Receives Complete Response Letter from FDA
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) (“Eagle” or “the Company”) announced today that it has received a Complete Response Letter from the U.S. Food and . . .
Posted on 7/26/17
Merck's Keynote Falls Flat, And That's Just Fine
With yesterday's failure of Keytruda in head and neck cancer comes yet more evidence that not all anti-PD-1 agents were created equal. It also raises fresh . . .
Posted on 7/26/17
Celgene: Gearing Up For New Highs
During my nearly decade long trading career, one sector I have always shied away from is Biotechnology (IBB). Volatility is rampant, things can turn on a . . .
Posted on 7/26/17
BrainStorm Announces Agreement with University of California Irvine Medical Center
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced that it has signed a definitive agreement . . .
Posted on 7/25/17
Proscia CEO to Present AI and Image Analysis Capabilities at 2017 MedCity CONVERGE Conference
Proscia Inc., a software solutions provider for digital pathology, announced today its CEO David West Jr. will be a featured panelist at 2017 MedCity CONVERGE. His . . .
Posted on 7/25/17
Quest Diagnostics Reports Second Quarter 2017 Financial Results
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the second quarter ended June 30, 2017 and . . .
Posted on 7/25/17
5 Things You Probably Didn't Know About Pfizer Inc.
Many people can name one of Pfizer's (NYSE:PFE) products. From over-the-counter products such as Advil and Robitussin to powerful prescription drugs such as Eliquis and Ibrance, . . .
Posted on 7/25/17
Better Buy: Johnson & Johnson vs. AbbVie
It's been a neck-and-neck race between Johnson & Johnson (NYSE:JNJ) and AbbVie(NYSE:ABBV) stocks so far in 2017. The two healthcare stocks are up by nearly identical . . .

